[L-dopa and bromocriptine in Parkinson disease. Early combination therapy has better effect].
Olsson
J E
JE
Neurologiska kliniken, Universitetssjukhuset, Linköping.
Duchek
M
M
Ekberg
R
R
Fehling
C
C
Johansson
F
F
Johnels
B
B
Lindvall
B
B
Nordin
G
G
Sidén
A
A
Steg
G
G
D001971:Bromocriptine / Q000008:administration & dosage* / Q000009:adverse effects; D004359:Drug Therapy, Combination; D004421:Dystonia / Q000139:chemically induced; D005260:Female; D006801:Humans; D006948:Hyperkinesis / Q000139:chemically induced; D007980:Levodopa / Q000008:administration & dosage* / Q000009:adverse effects; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology; D013997:Time Factors
D001971:Bromocriptine; D007980:Levodopa
L-dopa och bromokriptin vid Parkinsons sjukdom. Tidig kombination ger b attre effekt.